For research use only. Not for therapeutic Use.
AJ2-30 is a SLCl5A4 inhibitor. AJ2-30 inhibits TLR9-mediated B cell activation. AJ2-30 block endogenous NOD signaling in human and mouse macrophages. AJ2-30 can be used for research of inflammation[1].
| Catalog Number | I040779 |
| CAS Number | 2700322-79-6 |
| Synonyms | N-[(9-ethylcarbazol-3-yl)methyl]-1-methylbenzimidazol-2-amine |
| Molecular Formula | C23H22N4 |
| Purity | ≥95% |
| InChI | InChI=1S/C23H22N4/c1-3-27-20-10-6-4-8-17(20)18-14-16(12-13-21(18)27)15-24-23-25-19-9-5-7-11-22(19)26(23)2/h4-14H,3,15H2,1-2H3,(H,24,25) |
| InChIKey | QKZNLVHPKAXDOL-UHFFFAOYSA-N |
| SMILES | CCN1C2=C(C=C(C=C2)CNC3=NC4=CC=CC=C4N3C)C5=CC=CC=C51 |
| Reference | [1]. Daniel Lazar, et al. Small molecule inhibitors of scl15a4 with anti-inflammatory activity. Patent. WO2021174023. |
